Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.785 USD | +2.90% | +7.72% | +84.48% |
05-07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
05-01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Other languages